Heterogeneity of breast cancer subtypes: molecular basis and impact on treatment
Sylvie Mader, Ph.D., Professor, Institute for Research in Immunology and Cancer, Department of Biochemistry and Molecular Biology, Université de Montréal
Sylvie Mader, Ph.D., Professor, Institute for Research in Immunology and Cancer, Department of Biochemistry and Molecular Biology, Université de Montréal
T.-C. Wu, M.D., Ph.D., Professor and Director of Gynecologic Pathology, Professor of Oncology, Obstetrics & Gynecology, and Molecular Microbiology & Immunology, Johns Hopkins University, Daniel Nathans Scholar, Academician, Academia Sinica
Michael M. Lederman M.D., LSMFT, Professor of Medicine. Professor of Pathology, Microbiology/Molecular Biology- Case Western Reserve University. Editor-in-Chief Pathogens and Immunity
James L. Riley, Ph.D., Professor of Microbiology, Perelman School of Medicine- University of Pennsylvania
Peter W. Hunt, M.D., Professor, Division of Experimental Medicine, Department of Medicine- University of California San Francisco; Co-Director of the UCSF-Bay Area CFAR for Basic and Translational Science
Mary Carrington, Ph.D., Director, Basic Science Program, Frederick National Laboratory for Cancer Research, Laboratory of Integrative Cancer Immunology- National Cancer Institute
Pei-Yong Shi, Ph.D., John Sealy Distinguished Chair in Innovations in Molecular Biology, Vice Chair for Innovation and Commercialization, Department of Biochemistry & Molecular Biology- University of Texas Medical Branch at Galveston
C. Sabrina Tan, M.D., Principal Investigator and CTU Principal Investigator, CVVR- Assistant Professor of Medicine, Harvard Medical School, Staff Physician, Division of Infectious Diseases, BIDMC
Robert Flaumenhaft- BIDMC
Robert Flaumenhaft, M.D., Ph.D., Professor of Medicine, Chief, Division of Hemostasis and Thrombosis, BIDMC- Harvard Medical School